NasalCrom extensions?
This article was originally published in The Tan Sheet
Executive Summary
Formulation, dosage research on cromolyn sodium 4% nasal spray could lead to expansion of Pharmacia's OTC allergic rhinitis treatment/prevention remedy. "Research approaches being considered are to evaluate less-frequent dosing, including increasing the number of sprays of cromolyn per administration, increasing the concentration of the agent, titrating from the current to a lower dosage and using on an as-needed basis," Paul Ratner, MD, University of Texas Health Sciences Center, et al., state in review article funded by Pharmacia, published in April Mayo Clinic Proceedings...
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.